Floxuridine
氟尿苷
Report date: 2023/02/21 16:23:15
NME
Base Information
Drug NameFloxuridine
Drug Alias Name +[14]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1970/12/18
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHospira Inc
China Registration ClassN/A
Develop Information
Active CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Inactive CompaniesThe Netherlands Cancer InstituteHospira Inc
Active Indications
Inactive Indications